NASDAQ:RCM - R1 RCM Stock Price, Forecast & News

R1 RCM trades on the NASDAQ under the ticker symbol "RCM."

R1 RCM Inc (NASDAQ:RCM) announced its earnings results on Tuesday, November, 5th. The healthcare provider reported $0.01 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.09 by $0.08. The healthcare provider had revenue of $301.20 million for the quarter, compared to analyst estimates of $302.85 million. R1 RCM had a positive return on equity of 100.31% and a negative net margin of 0.13%. The company's revenue for the quarter was up 20.3% compared to the same quarter last year. During the same quarter last year, the business earned ($0.17) EPS. View R1 RCM's Earnings History.

R1 RCM is scheduled to release their next quarterly earnings announcement on Friday, February 28th 2020. View Earnings Estimates for R1 RCM.

4 Wall Street analysts have issued 1-year target prices for R1 RCM's shares. Their forecasts range from $14.00 to $17.00. On average, they anticipate R1 RCM's share price to reach $15.25 in the next twelve months. This suggests a possible upside of 15.1% from the stock's current price. View Analyst Price Targets for R1 RCM.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for R1 RCM in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for R1 RCM.

Media headlines about RCM stock have trended very positive recently, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. R1 RCM earned a daily sentiment score of 3.9 on InfoTrie's scale. They also assigned media stories about the healthcare provider a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for R1 RCM.

R1 RCM saw a increase in short interest during the month of December. As of December 31st, there was short interest totalling 7,780,000 shares, an increase of 17.3% from the December 15th total of 6,630,000 shares. Based on an average daily trading volume, of 1,130,000 shares, the short-interest ratio is currently 6.9 days. Currently, 8.0% of the shares of the company are sold short. View R1 RCM's Current Options Chain.

Some companies that are related to R1 RCM include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), Davita (DVA), Chemed (CHE), Amedisys (AMED), LHC Group (LHCG), AMN Healthcare Services (AMN), BioScrip (BIOS), MEDNAX (MD), CorVel (CRVL), Tivity Health (TVTY), The Providence Service (PRSC), Cross Country Healthcare (CCRN) and Interpace Diagnostics Group (IDXG).

Based on aggregate information from My MarketBeat watchlists, some companies that other R1 RCM investors own include Alibaba Group (BABA), NVIDIA (NVDA), Baozun (BZUN), Marvell Technology Group (MRVL), JD.Com (JD), NMI (NMIH), Booz Allen Hamilton (BAH), Skechers USA (SKX), Change Healthcare (CHNG) and Fortinet (FTNT).

R1 RCM's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Mckinley Capital Management LLC Delaware (0.28%), Hennessy Advisors Inc. (0.24%), Tealwood Asset Management Inc. (0.19%), Falcon Point Capital LLC (0.17%), Calamos Advisors LLC (0.09%) and Campbell & CO Investment Adviser LLC (0.03%). Company insiders that own R1 RCM stock include Albert Rene Zimmerli and Charles J Ditkoff. View Institutional Ownership Trends for R1 RCM.

RCM stock was sold by a variety of institutional investors in the last quarter, including Falcon Point Capital LLC, Calamos Advisors LLC and Hennessy Advisors Inc.. View Insider Buying and Selling for R1 RCM.

RCM stock was acquired by a variety of institutional investors in the last quarter, including Mckinley Capital Management LLC Delaware, Tealwood Asset Management Inc., Campbell & CO Investment Adviser LLC, NEXT Financial Group Inc, FNY Investment Advisers LLC and Global Retirement Partners LLC. View Insider Buying and Selling for R1 RCM.

Shares of RCM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of RCM stock can currently be purchased for approximately $13.25.

R1 RCM has a market capitalization of $1.50 billion and generates $868.50 million in revenue each year. The healthcare provider earns $-45,300,000.00 in net income (profit) each year or ($0.32) on an earnings per share basis. R1 RCM employs 18,600 workers across the globe.View Additional Information About R1 RCM.

The official website for R1 RCM is http://www.r1rcm.com/.

R1 RCM's mailing address is 401 NORTH MICHIGAN AVENUE SUITE 2700, CHICAGO IL, 60611. The healthcare provider can be reached via phone at 312-324-7820 or via email at [email protected]